4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Linifanib/SYN-1002-M010/10 mg
商品详细Adipogen/Linifanib/SYN-1002-M010/10 mg
Adipogen/Linifanib/SYN-1002-M010/10 mg
Adipogen/Linifanib/SYN-1002-M010/10 mg
商品编号: SYN-1002-M010
品牌: Adipogen Inc
市场价: ¥4320.00
美元价: 2592.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsABT-869;AL39324;RG-3635
ProductTypeChemical
Properties
FormulaC21H18FN5O
MW375.4
CAS796967-16-3
PurityChemicals≥95%
AppearanceSolid.
SolubilitySolubleinDMSOorethanol.
DeclarationManufacturedbySynKinase.
OtherProductDataTarget:PDGFR|KinaseGroup:RTK|Substrate:Tyrosine

ClickhereforOriginalManufacturerProductDatasheet
Ourproductdescriptionmaydifferslightlyfromtheoriginalmanufacturersproductdatasheet.
InChiKeyMPVGZUGXCQEXTM-UHFFFAOYSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
Linifanib(A741439;A-741439;A741439;ABT-869;ABT869;RG3635)isanorallyactivemulti-targetedreceptortyrosinekinaseinhibitorforthetreatmentofvariouscancers.Thecompoundisdesignedtoinhibitvascularendothelialgrowthfactorandplatelet-derivedgrowthfactorreceptorsandisamultitargetedtyrosinekinasereceptorinhibitorthatsuppressesFLT3signaling.ItisinphaseIIIdevelopmentforlivercancerandphaseIIdevelopmentfornon-smallcelllungcancer,breastcancer,andcolorectalcancer.RecentresearchalsoindicatesthatLinifanibinhibitsproliferationandinducesapoptosisinAMLpatientcellsviareductionofAKTandGSK3βphosphorylationandmaybeinfluencialinAMLtherapy.
ProductReferences
  1. DiscoveryofN-(4-(3-amino-1H-indazol-4-yl)phenyl)-N"-(2-fluoro-5-methylphenyl)urea(ABT-869),a3-aminoindazole-basedorallyactivemultitargetedreceptortyrosinekinaseinhibitor:Y.Dai,etal.;J.Med.Chem.50,1584(2007)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。